Overview Agenda Speakers Sponsors Register Venue Contact Us Testimonials

Founding Sponsor

Platinum Sponsors

Gold Sponsors

Silver Sponsor

Marketing Solutions Sponsor

Industry Partners




Wednesday, April 2, 2014

VENTURE SUMMIT & COMPANY PRESENTATIONS



8:00 a.m.

REGISTRATION

 

 

8:50 a.m.

WELCOME REMARKS 

   
9:00 a.m. THE LIFE SCIENCE ROAD MAP – VC OUTLOOK 2014
Life Science VCs, possessing strong industry savvy, are always on the pulse of the newest bioscience frontiers and keenly seek to invest in opportunities that monetize these advancements. Where are Life Science VCs currently focusing? More importantly, where will they be focusing? This panel of seasoned investors will examine the shifting paradigms and trends in drug development and healthcare delivery, and where these trends are heading in 2014.

Bob Curry
Partner
Latterell Venture Partners

Doug Fisher
Partner
Interwest Partners

Stephen Knight
Managing Partner
Fidelity Biosciences

Jordan Michael Kramer
Director
Kaiser Permanente Ventures

Vincent Miles
Partner
Abingworth

Liam Ratcliffe
Managing Director
New Leaf Venture Partners

Bruce Robertson
Managing Director
H.I.G. BioVentures
 
9:50 a.m.

BREAK 

   
10:00 a.m.

COMPANY PRESENTATIONS - ROUND I
Track I: Biotech & Pharma
Track II: Med Devices/Diagnostics/Healthcare/Life Sciences
Track III: Healthcare IT

   
11:00 a.m.

NETWORKING & REFRESHMENT BREAK

   
11:40 a.m.

COMPANY PRESENTATIONS - ROUND II
Track I: Biotech & Pharma
Track II: Med Devices/Diagnostics/Healthcare/Life Sciences
Track III: Healthcare IT



12:50 pm

LUNCH & NETWORKING

   
1:50 p.m.

COMPANY PRESENTATIONS – ROUND III

Track I: Biotech & Pharma
Track II: Med Devices/Diagnostics/Healthcare/Life Sciences
Track III: Healthcare IT

   
3:00 p.m.

CONCURRENT PANELS:

THE DNA OF NEGOTIATING A WINNING  DEAL
You've got a top notch team, solid business model and a term-sheet in hand, yet without understanding the negotiating process, you may wind up losing it all. This session will provide valuable insight from VCs who have been on the other side negotiating the elements necessary for structuring a winning opportunity.

MODERATOR

Dov Hass
Associate
Morgan, Lewis & Bockius LLP

PANELISTS

Nat Brinn
Partner
Vital Venture Capital

Skip Fleshman
Managing Partner
Asset Management Ventures

Gregory Grunberg
Managing Director
Longitude Capital

Cynthia Lavoie
General Partner
TVM Life Science Management

Jim Macdonald
Managing Director
First Analysis

Lisa Rhoads
Managing Director
Easton Capital Investment Group

Anthony Sun
Partner
Aisling Capital
 
FUNDING  HEALTHCARE IT & MEDIA
A prominent panel of VCs will discuss opportunities and trends for investing in Healthcare IT & Media Startups

MODERATOR

Aron Izower
Partner
Reed Smith LLP

PANELISTS

Steve Brotman
Managing Partner
Alpha Venture Partners

Carter Caldwell
Principal
Cross Atlantic Capital Partners

David Eichler
Managing Member
Psilos

Linda Fingerle
Chief Financial Officer & Principal
EDF Ventures

Guy Fish
Vice President
Fletcher Spaght Ventures

Akhil Saklecha
Partner
Artiman Ventures

Jeremy Sohn
Managing Director
MPM Capital

   
3:50 p.m.

NETWORKING & REFRESHMENT BREAK

   
4:30 p.m.

CONCURRENT PANELS:
 
STRATEGIC VENTURE FUNDING: WHAT YOU NEED TO KNOW
With a new flowering of startup innovation, many giants of industry have decided to enter or re-enter the world of VC. This session will explore the value-added investment approach of Corporate VCs and how it yields important dividends that are “beyond the bottom line,” both for the investor and for the startup.

MODERATOR

Allison Conkright Engel

Dell Center for Entrepreneurs

PANELISTS

Eric Bielke
Senior Investment Associate
Siemens Venture Capital

Ela Borenstein
Managing Partner
BDC Healthcare Fund

Rajeev Dadoo
Partner
SR One

Inès Holzbaur
General Partner
GeneChem Management

Marian Nakada
Vice President, Venture Investments
Johnson & Johnson Development Corporation
 
VC CHECKUP
Case studies, VCs compare and contrast the growth of seemingly healthy companies. What did these companies do right? Where did they go wrong? Which one would be considered a healthier investment and why? Does your company measure up? What healthy habits will make your company a more desirable investment? Growing into a revenue generating company takes more than money. Find out if you pass the VC checkup.

Matt Cohen
Associate
Osage University Partners

Jim Dougherty
General Partner
Arcus Ventures

Suzette Dutch
Managing Partner
Triathlon Medical Ventures

Jim Gunton
General Partner
NJTC Venture Fund

Noah Kroloff
Partner
NGN Capital

Corey McCann
Principal
MPM Capital

Tracy Warren
General Partner
Battelle Ventures

   
5:20 p.m.

AWARDS & CLOSING REMARKS



5:30 p.m.

SUMMIT ADJOURNS

   



* Program schedules and speakers are subject to change